4//SEC Filing
Clovis Oncology, Inc. 4
Accession 0001209191-13-055788
CIK 0001466301operating
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 8:00 PM ET
Size
11.3 KB
Accession
0001209191-13-055788
Insider Transaction Report
Form 4
SPICKSCHEN THORLEF
Director
Transactions
- Sale
Common Stock
2013-12-04$56.38/sh−3,000$169,138→ 40,427 total - Sale
Common Stock
2013-12-05$55.96/sh−6,000$335,787→ 34,427 total
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $56.25 to $56.56. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $55.81 to $56.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001466301
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 8:00 PM ET
- Size
- 11.3 KB